Back to Blog
CAFC-PTOAugust 27, 2026·25-2099·Dismissed; order issued as the mandate on August 27, 2026.

Aerin Medical Inc. v. Neurent Medical Inc.

Patent Trial and Appeal Board

Holding

The Federal Circuit dismissed the appeals under Federal Rule of Appellate Procedure 42(b) by party agreement. Each side will bear its own costs.

Why It Matters

The order ends these PTAB appeals without any Federal Circuit merits ruling on the underlying IPR issues.

Full Summary

Aerin Medical Inc. v. Neurent Medical Inc. [Order] The Federal Circuit dismissed the appeals under Federal Rule of Appellate Procedure 42(b) by party agreement. Each side will bear its own costs. The order ends these PTAB appeals without any Federal Circuit merits ruling on the underlying IPR issues. Dismissed; order issued as the mandate on August 27, 2026. The appeals arose from six PTAB IPR proceedings involving Aerin Medical, The Foundry, and Neurent entities. The Federal Circuit did not address patentability, claim construction, or any other merits issue. Dismissal was entered under FRAP 42(b) based on the parties' agreement. The court ordered each side to bear its own costs and issued the order as the mandate the same day. non-precedential waiver / forfeiture claim construction non-precedential waiver / forfeiture claim construction non-precedential waiver / forfeiture

Key Points

  • The appeals arose from six PTAB IPR proceedings involving Aerin Medical, The Foundry, and Neurent entities.
  • The Federal Circuit did not address patentability, claim construction, or any other merits issue.
  • Dismissal was entered under FRAP 42(b) based on the parties' agreement.
  • The court ordered each side to bear its own costs and issued the order as the mandate the same day.
non-precedentialwaiver / forfeitureclaim construction

More on this topic